Combined flu-Covid vaccine: Pfizer will test its 2-in-1 serum this week

Pfizer-BioNTech will test a 2-in-1 vaccine combining that against influenza and that against Covid-19, the laboratories announced on Thursday, November 3, in a press release.

Get vaccinated against the flu then Covid-19 or vice versa or both at the same time? Yes, the last option could become possible very soon. In effect, the Pfizer-BioNTech alliance announced this Thursday, November 3, that it launched the first phase of a trial of a combination vaccine targeting both influenza and Covid-19reveals Le Point.

A miracle recipe to try

In an article in Le Parisien, the American pharmaceutical giant details that its vaccine will combine the Pfizer-BioNTech vaccine adapted to the Omicron variant and the Pfizer flu vaccine “currently in phase 3”.

“The study is based in the United States and includes 180 participants aged 18 to 64“, indicates Ouest France, which quotes Pfizer. The first participants will receive a dose this week.

RNA to simplify vaccinations

For this new vaccine, messenger RNA technology will be used. This last “could simplify vaccination practices against these two respiratory pathogens, potentially leading to better vaccination coverage for both diseases”, explains Annaliesa Anderson, scientific director at Pfizer, in a press release quoted by La Provence.

“The flexibility and speed of production of the technology to messenger RNAs are ideal for other forms of respiratory disease“, continues Annaliesa Anderson.

Leave a Comment